Ambroxol: all 21 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- An Open Label Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacologic Properties of High Dose Ambroxol Hydrochloride in Adult (≥ 18 Years of Age) Subjects With MPS IIIRecruitingNCT06614894Phase 2/3
- High-Dose Ambroxol in GBA1-Related ParkinsonRecruitingNCT06193421Phase 1/2
- A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALSRecruitingNCT05959850Phase 2
- GRoningen Early-PD Ambroxol TreatmentRecruitingNCT05830396Phase 2/3
- Ambroxol to Slow Progression in Parkinson DiseaseRecruitingNCT05778617Phase 3
- Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical TrialRecruitingNCT04588285Phase 2
- Ambroxol as a Novel Disease Modifying Treatment for Lewy Body DementiaNot yet recruitingNCT04405596Phase 1/2
- Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore ThroatCompletedNCT00525044Phase 3Results posted
- High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)CompletedNCT07285369Not applicable
- Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill PatientsCompletedNCT05663905Phase 4
- Effect of Ambroxol in Diabetic Peripheral NeuropathyStatus unknownNCT05558878Not applicable
- Ambroxol as a Disease-modifying Treatment in GBA-PDCompletedNCT05287503Phase 2
- Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement TherapyCompletedNCT03950050Phase 2
- A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough.CompletedNCT03415269Phase 2
- Ambroxol in Disease Modification in Parkinson DiseaseCompletedNCT02941822Phase 2
- Ambroxol as a Treatment for Parkinson's Disease DementiaActive, not recruitingNCT02914366Phase 2
- Effects of Oral Mucolytics on Tear Film and Ocular SurfaceCompletedNCT01713179Phase 1/2
- A Drug-Drug Interaction Study of Ambroxol and LevodropropizineCompletedNCT01573663Phase 1
- Clinical Trial of Ambroxol in Patients With Type I Gaucher DiseaseSuspendedNCT01463215Phase 1/2
- Ambroxol Spray Sore Throat StudyCompletedNCT01361802Phase 2
- Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/ViralpharyngitisCompletedNCT00148499Phase 3